Patients with primary myelofibrosis: treatment and quality of life
<p>Primary myelofibrosis (PMF) is one of the diseases that cannot be cured using modern methods of conservative therapy. Therefore, treatment aimed at reducing PMF severity and improving patient’s quality of life. In this article, a comparative analysis of treatment response and quality of lif...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | http://oncohematology.abvpress.ru/index.php/ongm/article/view/56 |
| _version_ | 1828047075199156224 |
|---|---|
| author | L. M. Meshcheryakova O. V. Porotkova L. G. Kovaleva L. Yu. Kolosova |
| author_facet | L. M. Meshcheryakova O. V. Porotkova L. G. Kovaleva L. Yu. Kolosova |
| author_sort | L. M. Meshcheryakova |
| collection | DOAJ |
| description | <p>Primary myelofibrosis (PMF) is one of the diseases that cannot be cured using modern methods of conservative therapy. Therefore, treatment aimed at reducing PMF severity and improving patient’s quality of life. In this article, a comparative analysis of treatment response and quality of life depending on therapy using was shown. Partial remission rate at approximately the same level after α-interferon treatment (55.3 %) and after cytotoxic drug (48.8 %) was observed. Significant improvement in quality of life during α-interferon treatment was revealed.</p> |
| first_indexed | 2024-04-10T18:35:45Z |
| format | Article |
| id | doaj.art-b8a954d6e8ba4f68b1cfbbff554d8a16 |
| institution | Directory Open Access Journal |
| issn | 1818-8346 |
| language | Russian |
| last_indexed | 2024-04-10T18:35:45Z |
| publishDate | 2014-07-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Онкогематология |
| spelling | doaj.art-b8a954d6e8ba4f68b1cfbbff554d8a162023-02-02T01:27:22ZrusABV-pressОнкогематология1818-83462014-07-017261371Patients with primary myelofibrosis: treatment and quality of lifeL. M. Meshcheryakova0O. V. Porotkova1L. G. Kovaleva2L. Yu. Kolosova3Hematological Research CenterRegional Clinical Hospital № 1Hematological Research CenterHematological Research Center<p>Primary myelofibrosis (PMF) is one of the diseases that cannot be cured using modern methods of conservative therapy. Therefore, treatment aimed at reducing PMF severity and improving patient’s quality of life. In this article, a comparative analysis of treatment response and quality of life depending on therapy using was shown. Partial remission rate at approximately the same level after α-interferon treatment (55.3 %) and after cytotoxic drug (48.8 %) was observed. Significant improvement in quality of life during α-interferon treatment was revealed.</p>http://oncohematology.abvpress.ru/index.php/ongm/article/view/56primary myelofibrosistreatmentquality of life |
| spellingShingle | L. M. Meshcheryakova O. V. Porotkova L. G. Kovaleva L. Yu. Kolosova Patients with primary myelofibrosis: treatment and quality of life Онкогематология primary myelofibrosis treatment quality of life |
| title | Patients with primary myelofibrosis: treatment and quality of life |
| title_full | Patients with primary myelofibrosis: treatment and quality of life |
| title_fullStr | Patients with primary myelofibrosis: treatment and quality of life |
| title_full_unstemmed | Patients with primary myelofibrosis: treatment and quality of life |
| title_short | Patients with primary myelofibrosis: treatment and quality of life |
| title_sort | patients with primary myelofibrosis treatment and quality of life |
| topic | primary myelofibrosis treatment quality of life |
| url | http://oncohematology.abvpress.ru/index.php/ongm/article/view/56 |
| work_keys_str_mv | AT lmmeshcheryakova patientswithprimarymyelofibrosistreatmentandqualityoflife AT ovporotkova patientswithprimarymyelofibrosistreatmentandqualityoflife AT lgkovaleva patientswithprimarymyelofibrosistreatmentandqualityoflife AT lyukolosova patientswithprimarymyelofibrosistreatmentandqualityoflife |